VESS2. Retrograde Aortic Dissection After Thoracic Endovascular Aortic Repair  by Canaud, Ludovic et al.
ABSTRACTS OF THE 2014 VASCULAR ANNUAL
MEETINGV1: Vascular and Endovascular Surgery Society Paper
Session I
VESS1.
A New Aortic Injury Score Predicts Early Rupture
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Objectives: Optimal timing for repair of thoracic
aortic injury (TAI) is uncertain. Delayed repair is common,
but some injuries may rupture during observation. To help
guide management, we describe a risk score to evaluate
TAI stability and predict rupture.
Methods: We retrospectively reviewed 49 patients
who presented in stable condition with Society for
Vascular Surgery (SVS) type III or IV TAI. Eighteen
developed rupture #48 hours, deﬁned as active extravasa-
tion on computed tomography (CT) imaging, or by
operative or autopsy ﬁndings. Thirty-one patients did
not rupture and were repaired $48 hours after admis-
sion. There was no difference in age, gender, injury
mechanism, severity of nonchest injury, blood pressure,
or Glasgow Coma Scale on admission between patients
who ruptured and those who did not. We generated a
model targeting 100% sensitivity for rupture and vali-
dated it by bootstrap analysis with 1000 replicates. The
model was compared with clinical assessment by surgeons
experienced in TAI management who were provided
with CT images and clinical data but were blinded to
outcome.
Results: Multivariate analysis identiﬁed lactate
>4 mM and mediastinal hematoma >10 mm (major
criteria), and lesion: normal aortic diameter ratio >1.4
and pulse >105 beats/min (minor criteria) as binary fac-
tors associated with rupture. A composite score was gener-
ated: (Lactate  4) + (Hematoma  4) + (Ratio  3) +
(Pulse  2). A score $8 identiﬁed 100% of those who
ruptured and one (3%) who did not as high-risk (P <
.0001). Sensitivity and negative-predictive value were
100%, speciﬁcity was 97%, and the area under the receiver
operating characteristic curve was 0.98. No patient with
score of <8 ruptured. The model predicts rupture with
two major or one major and two minor criteria. Clinical
assessment did not reliably predict rupture (65%, P <
.0001; 73% sensitivity and 61% speciﬁcity).4SConclusions: This risk score can be calculated on
admission and identiﬁes patients with TAI at high risk for
early rupture. Because the model is more accurate than
clinical assessment alone, it may help guide appropriate
early management.
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Objectives: To provide data regarding the etiology and
timing of retrograde type A aortic dissection (RTAD) after
thoracic endovascular aortic repair (TEVAR).
Methods: Details of patients who had RTAD after
TEVAR were obtained from the Medtronic Thoracic
Endovascular Registry (MOTHER), supplemented by
data from a systematic review of the literature (EMBASE,
MEDLINE, and Cochrane databases). Univariate analysis
and binary logistic regression analysis of patient or technical
factors was performed to test for possible associations with
RTAD.
Results: In MOTHER, RTAD developed in 16 of the
1010 patients (1.6%). Binary logistic regression demon-
strated that an indication of TEVAR for aortic dissection
(acute P ¼ .000212; chronic P ¼ .006) and device oversiz-
ing (odds ratio, 1.14 per 1% increase in oversizing above
9%; P < .0001) were signiﬁcantly more frequent in patients
with RTAD. Data from the systematic review was pooled
with MOTHER data and demonstrated that RTAD
occurred in 1.7% (168 of 9594). Most RTAD (58%)
occurred in the immediate postoperative period and was
associated with a high mortality rate (33.6%). The odds ra-
tio of RTAD for an acute aortic dissection was 7.8 (conﬁ-
dence interval, 3.8-17.8) and 2.7 (conﬁdence interval,
1.04-6.9) for chronic aortic dissection. The incidence of
RTAD was not signiﬁcantly different for endografts with
a proximal bare stent (2.8%) or nonbare stent (2.4%).
Conclusions: Although RTAD after TEVAR is an un-
common complication, it has a high mortality rate. RTAD
is signiﬁcantly more frequent in patients treated for acute
and chronic type B dissection, and when the endograft is
signiﬁcantly oversized. The proximal endograft conﬁgura-
tion was not associated with any difference in the incidence
of RTAD.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 6S Abstracts 5SAuthor Disclosures: L. Canaud: Nothing to disclose;
P. Holt: Nothing to disclose; B. A. Ozdemir: Nothing
to disclose; M. Thompson: Nothing to disclose.
VESS3.
Type II Endoleak With or Without Intervention After
Endovascular Aortic Aneurysm Repair (EVAR) Does
Not Change Long-Term Outcomes Despite Aneurysm
Sac Growth
Joy Walker1, Lue-Yen Tucker2, Philip Goodney3, Hong
Hua4, Steven Okuhn4, Ann Rhoades5, Bradley Hill6,
Robert W. Chang7. 1University of California, San
Francisco, Calif; 2Kaiser Permanente, Division of Research,
Oakland, Calif; 3Dartmouth-Hitchcock Medical Center,
Lebanon, NH; 4The Permanente Medical Group, San
Francisco, Calif; 5Kaiser Permanente, Oakland, Calif; 6The
Permanente Medical Group, Santa Clara, Calif; 7The
Permanente Medical Group, South San Francisco, Calif
Objectives: There is considerable controversy
regarding the signiﬁcance and appropriate treatment of
type II endoleaks (T2L) after EVAR. We report our
long-term experience with T2L management in a large
multicenter registry.
Methods: Between 2000 and 2010, 1736 patients un-
derwent EVAR. The incidence of T2L was observed. Pri-
mary outcomes were mortality and aneurysm-related
mortality (ARM). Secondary outcomes were change in
aneurysm sac size and reintervention.
Results: During the median follow-up of 32.2 months
(interquartile range, 14.2-52.8 months), there were 474
T2L (27.3%). There were no late abdominal aortic aneurysm
ruptures attributable to a T2L. Patients with T2L had no dif-
ference in overall mortality (P ¼ .47) or ARM (P ¼ .26)
compared with those without T2L. A median sac growth
of 5 mm (interquartile range, 2-10 mm) was seen in 46.1%
of patients with T2L. Of these, 11.0% had an additional
type of endoleak. Reintervention occurred in 111 (23.4%)
of all patients with T2L, of which 74%were performed in pa-
tients with sac growth, and was technically successful in
31.5% of cases. Thirty-nine patients (35.1%) underwent lum-
bar embolization, 31 (27.9%) had adjunctive stents placed, 7
(6.3%) had open surgical revision, and 3 (2.7%) had direct sac
injection. Thirty-one patients (27.9%) hadmultiple interven-
tions. After excluding patients with other types of endoleak,
patients with T2L-associated sac growth had no difference in
overall mortality (P ¼ .57) or ARM (P ¼ .09), with or
without reintervention.
Conclusions: In our multicenter EVAR registry, over-
all mortality and ARM were unaffected by the presence of a
T2L. Moreover, patients who were simply observed for
T2L-associated sac growth had similar outcomes as those
who underwent reintervention for the same, suggesting
that concomitant other endoleak types may be the primary
driver of mortality. Our future work will investigate the
most cost-effective ways to select patients for intervention
besides sac growth alone.
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Objectives: To evaluate the implications of thoracic and
abdominal aortic false lumen embolization (FLE) during
thoracic endovascular aortic repair (TEVAR) and endovascu-
lar aneurysm repair (EVAR) for complicated aortic dissections.
Methods: Ninety-six consecutive patients who pre-
sented with complicated acute and chronic type B thoracic
aortic dissections (TAD) who underwent TEVAR with FLE
(n ¼ 32 [33.3%]) and without FLE (n ¼ 52 [54.2%]), as
well as abdominal aortic dissections (AAD) who underwent
EVAR with FLE (n ¼ 4 [4.2%]) and without FLE (n ¼ 8
[8.3%]). In a subset of 26 patients, before FLE, a wireless
cardioMEMS Endosure pressure sensor was placed in the
false lumen and used to quantify the false lumen to systemic
systolic, diastolic, mean, pulse pressure indices. All data
were prospectively collected and outcomes analyzed.
Results: The 30-day mortality in patients with FLE
(n¼ 1 [2.3%]) was signiﬁcantly lower than patients without
FLE (n ¼ 5 [9.6%]), and none of the patients with FLE
developed spinal cord ischemia. After TEVAR and FLE,
nine patients (29.0%) had persistent retrograde false lumen
endoleaks that required repeat embolization procedures.
FLE and complete thrombosis was achieved in 100% of
EVAR patients. At a mean 18-month follow-up, 88% (23
of 26 patients) had a signiﬁcant decrease in all false lumen-
to-systemic pressure indices, and 65% (17 of 26 patients)
had a false lumen remodeling with>5 mmmaximum diam-
eter reduction. At midterm follow-up, there are no thoracic
or abdominal related ruptures, conversions, or deaths.
Conclusions: FLE during TEVAR for complicated
acute and chronic TAD and AAD is associated with a lower
mortality and is effective in reducing false lumen pressures
and maximum diameter. This adjunctive technique should
be consideredwhenmanaging complicated aortic dissections.
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